Then, melanoma cells expressing a high level of costimulatory molecules directly present a tumor-associated antigen (TAA)–MHC compound to CD8+T cells, stimulating the production of interleukin 2 (IL-2) that leads to their proliferation and differentiation to cytotoxic T cells (CTL). This evidence concerns the gene CD8A and melanoma.